Includes Powerful New In Silico Models and
First-to-Market Software Capabilities
Haisco Pharmaceutical Group Strengthens Drug Discovery Processes
with Instem’s
KnowledgeScan™ Target Safety Assessment Service
Join the journey with us by visiting
one of our bi-weekly industry Blogs
Acquisition of PDS Life Sciences Consolidates Non-Clinical Market; Further Extends Instem’s Leadership in Study Management and Regulatory SEND Submission Support
Powerful New In Silico Models and First-to-Market Software Capabilities to Deliver Further Efficiencies and Increased Regulatory Compliance
Instem’s Acquisition of Leading Clinical Trial Technology and Consulting Provider d-wise Represents Substantial Advancement of its Mission
To help you better evaluate our software or services, we believe an initial, no pressure Web session is the way to go.
© 2021 Instem Group of Companies